169 related articles for article (PubMed ID: 38413535)
1. Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation and disease progression in cirrhosis.
Xu L; Huang C; Zheng X; Gao H; Zhang S; Zhu M; Dai X; Wang G; Wang J; Chen H; Zhu H; Chen Z
Clin Exp Med; 2024 Feb; 24(1):45. PubMed ID: 38413535
[TBL] [Abstract][Full Text] [Related]
2. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
[TBL] [Abstract][Full Text] [Related]
3. Expression of LAIR-1 (CD305) on Human Blood Monocytes as a Marker of Hepatic Cirrhosis Progression.
Martínez-Esparza M; Ruiz-Alcaraz AJ; Carmona-Martínez V; Fernández-Fernández MD; Antón G; Muñoz-Tornero M; Lencina M; Pagán I; de la Peña J; García-Peñarrubia P
J Immunol Res; 2019; 2019():2974753. PubMed ID: 31019980
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
[TBL] [Abstract][Full Text] [Related]
5. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
6. Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes.
Asano K; Takahashi N; Ushiki M; Monya M; Aihara F; Kuboki E; Moriyama S; Iida M; Kitamura H; Qiu CH; Watanabe T; Tanaka M
Nat Commun; 2015 Jul; 6():7802. PubMed ID: 26193821
[TBL] [Abstract][Full Text] [Related]
7. Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury.
Karasawa K; Asano K; Moriyama S; Ushiki M; Monya M; Iida M; Kuboki E; Yagita H; Uchida K; Nitta K; Tanaka M
J Am Soc Nephrol; 2015 Apr; 26(4):896-906. PubMed ID: 25266072
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
9. A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.
Li C; Luo X; Lin Y; Tang X; Ling L; Wang L; Jiang Y
PLoS One; 2015; 10(10):e0141817. PubMed ID: 26509874
[TBL] [Abstract][Full Text] [Related]
10. Monocytes and macrophages as cellular targets in liver fibrosis.
Heymann F; Trautwein C; Tacke F
Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
[TBL] [Abstract][Full Text] [Related]
11. Blood monocyte-derived CD169
Kim HJ; Park JH; Kim HC; Kim CW; Kang I; Lee HK
Nat Commun; 2022 Oct; 13(1):6211. PubMed ID: 36266311
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS.
Kim WK; McGary CM; Holder GE; Filipowicz AR; Kim MM; Beydoun HA; Cai Y; Liu X; Sugimoto C; Kuroda MJ
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):696-706. PubMed ID: 25891017
[TBL] [Abstract][Full Text] [Related]
13. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.
Moore JK; Mackinnon AC; Wojtacha D; Pope C; Fraser AR; Burgoyne P; Bailey L; Pass C; Atkinson A; Mcgowan NW; Manson L; Turner ML; Campbell JD; Forbes SJ
Cytotherapy; 2015 Nov; 17(11):1604-16. PubMed ID: 26342993
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
16. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients.
Cardoso CC; Matiollo C; Pereira CHJ; Fonseca JS; Alves HEL; da Silva OM; de Souza Menegassi V; Dos Santos CR; de Moraes ACR; de Lucca Schiavon L; Santos-Silva MC
Sci Rep; 2021 Mar; 11(1):5923. PubMed ID: 33723292
[TBL] [Abstract][Full Text] [Related]
17. CD169 Defines Activated CD14
Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
Front Immunol; 2021; 12():697840. PubMed ID: 34394090
[TBL] [Abstract][Full Text] [Related]
18. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Jalloh S; Olejnik J; Berrigan J; Nisa A; Suder EL; Akiyama H; Lei M; Tyagi S; Bushkin Y; Mühlberger E; Gummuluru S
bioRxiv; 2022 Mar; ():. PubMed ID: 35378756
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
Zimmermann HW; Seidler S; Gassler N; Nattermann J; Luedde T; Trautwein C; Tacke F
PLoS One; 2011; 6(6):e21381. PubMed ID: 21731723
[TBL] [Abstract][Full Text] [Related]
20. Macrophage heterogeneity in liver injury and fibrosis.
Tacke F; Zimmermann HW
J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
